Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/12/2009WO2009137454A1 7h-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
11/12/2009WO2009137413A1 Therapeutic cyclopentane derivatives
11/12/2009WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009WO2009137400A2 Protection of normal cells
11/12/2009WO2009137391A2 Benzene sulfonamide thiazole and oxazole compounds
11/12/2009WO2009137380A1 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
11/12/2009WO2009137378A2 Sequential administration of chemotherapeutic agents for treatment of cancer
11/12/2009WO2009137345A1 Therapeutic compounds
11/12/2009WO2009137343A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009WO2009137342A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [ 3, 2, 1-i j ] quinoline compounds
11/12/2009WO2009137340A1 Alpha2b and alpha2c agonists
11/12/2009WO2009137338A1 Pyrazole compounds as ccr1 antagonists
11/12/2009WO2009137334A2 Method for treating neurodegenerative dysfunction
11/12/2009WO2009137308A1 Selective ligands for the neuronal nicotinic receptors and uses thereof
11/12/2009WO2009137291A2 Spiroazaindoles
11/12/2009WO2009137251A2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
11/12/2009WO2009137201A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/12/2009WO2009137133A2 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
11/12/2009WO2009137104A1 Combination therapy for breastcancer comprising an antiestrogenic agent
11/12/2009WO2009137100A2 Proguanil to treat skin/mucosal diseases
11/12/2009WO2009137098A1 Method for treatment of glioblastoma multiforme using talampanel
11/12/2009WO2009137087A2 A method for preventing or alleviating the noxious effects resulting from toxicant exposure
11/12/2009WO2009137086A1 Oral administration of peripherally-acting opioid antagonists
11/12/2009WO2009137085A2 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
11/12/2009WO2009137082A1 4-isopropylcyclohexylcarbonyl amino acid derivatives
11/12/2009WO2009137081A2 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/12/2009WO2009137074A1 Compositions and methods for treating diabetic ulcers
11/12/2009WO2009137067A1 Controlled release formulations of alprazolam
11/12/2009WO2009137044A2 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells
11/12/2009WO2009136997A2 Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
11/12/2009WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009WO2009136979A2 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
11/12/2009WO2009136966A1 Inhibitors of protein kinases
11/12/2009WO2009136965A1 Compositions and methods comprising capuramycin analogues
11/12/2009WO2009136889A1 Specific inhibitors for vascular endothelial growth factor receptors
11/12/2009WO2009136884A2 Metformin-pioglitazone formulation with antihyperglycemic effects
11/12/2009WO2009136850A1 Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia
11/12/2009WO2009136814A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136813A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136663A1 Fused heterocyclic derivatives and use thereof
11/12/2009WO2009136651A1 Topical composition for external use and process for producing the same
11/12/2009WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases
11/12/2009WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009WO2009136617A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/12/2009WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009WO2009136587A1 Anti-fatigue composition
11/12/2009WO2009136572A1 Polymer conjugate of folic acid or folic acid derivative
11/12/2009WO2009136563A1 Moisturizing agent
11/12/2009WO2009136501A1 Method and kit for detection of cancer, and therapeutic agent for cancer
11/12/2009WO2009136408A1 Synergistic pharmaceutical cocrystals
11/12/2009WO2009136396A2 Sulfobetaines for therapy
11/12/2009WO2009136392A2 Methods and compositions for oral administration of exenatide
11/12/2009WO2009136379A1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
11/12/2009WO2009136375A1 Treatment of interstitial cystitis
11/12/2009WO2009136350A1 Novel class of spiro piperidines for the treatment of neurodegenerative diseases
11/12/2009WO2009136282A1 Combination products for treating cancer
11/12/2009WO2009136281A1 Nitric oxide donating prostamides
11/12/2009WO2009136214A1 Combination compositions comprising antimycotic agents and statins and the use thereof
11/12/2009WO2009136191A1 Chemical compounds
11/12/2009WO2009136176A1 Compositions and methods for the treatment of fibromyalgia
11/12/2009WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009WO2009136162A1 Intermediate and processes involved in the preparation of 2 ' -cyano-2 ' -de0xy-n4-palmit0yl-1-beta-arabin0furan0sylcytosine
11/12/2009WO2009136158A1 Preparation of intermediates useful in the syntheis of 2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
11/12/2009WO2009136144A1 Purine derivatives suitable for the treatment of cancer, autoimmune and inflammatory diseases
11/12/2009WO2009136056A2 High-fluidity and non-caking pulverulent crystalline maltitol composition
11/12/2009WO2009136001A1 Protein kinase modulating agents
11/12/2009WO2009135960A1 Carbohydrate mixture and the use thereof for preparing a product for oral or enteral nutrition
11/12/2009WO2009135959A1 Food product for enterally or orally feeding diabetic patients
11/12/2009WO2009135951A2 Process for preparing a tablet comprising metformin
11/12/2009WO2009135944A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/12/2009WO2009135927A1 Substituted n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
11/12/2009WO2009135925A1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
11/12/2009WO2009135918A1 Compositions and processes for preparing them
11/12/2009WO2009135890A1 Intercalating triplexes and duplexes using aryl naphthoimidazol and process for the preparation thereof
11/12/2009WO2009135885A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/12/2009WO2009135867A1 Sialic acid to support salivation
11/12/2009WO2009135858A1 Sialic acid to support the immune system in the elderly
11/12/2009WO2009135846A1 Opioid composition for treating skin lesions
11/12/2009WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009WO2009135788A1 Heterocyclic antiviral compounds
11/12/2009WO2009135651A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
11/12/2009WO2009135646A2 Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
11/12/2009WO2009135599A1 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
11/12/2009WO2009135593A2 Solid pharmaceutical formulation with delayed release
11/12/2009WO2009135590A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009WO2009135583A1 Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
11/12/2009WO2009135579A1 Polymorph of 8-hydroxy-5- [(1r)-1-hydroxy-2- [[(1r) -2-(4-methoxyphenyl) -1-methylethyl] amino] ethyl] -2(1h)-quinolinone monohydrochloride
11/12/2009WO2009135577A1 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2- (4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)- quinolinone monohydrochloride
11/12/2009WO2009135526A1 Alpha-mercapto-amides
11/12/2009WO2009135520A1 Sustained release microtablets comprising tolterodine tartrate
11/12/2009WO2009135495A1 Method for treating cognitive deficits
11/12/2009WO2009135449A1 LIGANDS OF ESTROGEN RECEPTORS α AND β, METHOD OF THEIR PREPARATION AND PHARMACEUTICALS COMPRISING THEM
11/12/2009WO2009135433A1 Use of total salvianolic acid, panax notoginsenosides and combination thereof in treating septicemia
11/12/2009WO2009135432A1 The use of salvianolic acid b on anti- thrombus
11/12/2009WO2009135423A1 Pharmceuttical composition for treating cardio-cerebro vascular diseases and preparative method and kit thereof
11/12/2009WO2009135322A1 Methods and compositions for the treatment of huntington's disease
11/12/2009WO2009135299A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/12/2009WO2009117584A3 Anti-inflammatory drug delivery system
11/12/2009WO2009117467A3 Therapeutic compounds
11/12/2009WO2009117378A3 Therapeutic amides
1 ... 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 ... 7860